CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


We found 6894 result(s)

pCODR Clinician Input and Feedback

Published on: August 9, 2018
Result type: General Content

The CADTH pan-Canadian Oncology Drug Review (pCODR) undertakes rigorous, objective reviews of cancer drugs and provides funding recommendations to Canada’s provinces and territories (except Quebec). Funders use this information as one element of their decision-making process to determine if a drug will be eligible for public reimbursement. ...

Expert Involvement in Scientific Advice

Published on: December 7, 2015
Result type: General Content

The CADTH Scientific Advice Program includes expert input as part of the process for developing Scientific Advice. Two clinical experts and one health economics expert (if relevant) will be engaged for each Scientific Advice application. Consideration may be given to engaging a past member of the Canadian Drug Expert Committee (CDEC) as one of t...

Stakeholder Feedback

Published on: March 22, 2015
Result type: General Content

CADTH formally solicits feedback from stakeholders (health care professionals, patients, drug manufacturers, associations, and other interested parties) on projects and draft reports. We value all feedback and use it to shape and improve our work. Calls for stakeholder feedback and respective deadlines are posted on the Open Calls for Feedback ...